Search Results for keywords:"Noroxymorphone"

Found 2 results

Search Results: keywords:"Noroxymorphone"

💰 Only
Oldest Newest
  • 2025-02597 — Importer of Controlled Substances Application: Veranova, L.P.
    Type:Notice
    Citation:90 FR 9554
    Reading Time:about 2 minutes

    Veranova, L.P. has applied to the Drug Enforcement Administration (DEA) to become an importer of specific controlled substances. These substances include Coca Leaves, raw Opium, Poppy Straw Concentrate, Thebaine, Noroxymorphone, and Fentanyl. The company intends to use these materials to manufacture active pharmaceutical ingredients and reference standards for testing purposes. The DEA invites public comments or objections by March 17, 2025, and requests for a hearing must be sent to the designated DEA addresses.

    Simple Explanation

    Veranova, L.P. wants to bring in certain strong and controlled substances to make medicine and test samples, and people have until March 17, 2025, to tell the DEA what they think about this idea.

  • 2025-07281 — Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US), LLC; Correction
    Type:Notice
    Citation:90 FR 17626
    Reading Time:less than a minute

    The Drug Enforcement Administration (DEA) issued a notice on April 28, 2025, correcting a previous document published in the Federal Register on March 26, 2025. The initial document contained incorrect information about a registrant's plans related to controlled substances. The correction specifies that Pharmaron Manufacturing Services intends to bulk manufacture Noroxymorphone as an intermediate product for its customers, using Oxymorphone as a starting material. The corrected notice also clarifies that no other activities involving these substances are authorized for this registration.

    Simple Explanation

    The government had to fix a mistake they made in a notice about a company that makes certain special medicines. Originally, they gave wrong details about what medicine the company wanted to make, so now they've corrected it to say the company plans to make a specific medicine for others to use in making more medicines.